Interim mortality in pulmonary atresia with intact ventricular septum

Kathleen N Fenton1, Frank A Pigula, Sanjiv K Gandhi

  • 1Department of Cardiothoracic Surgery, Children's Hospital, Omaha, Nebraska 68114, USA. kfenton@chsomaha.org

Insights

Interim mortality is significant in infants with pulmonary atresia and hypoplastic right ventricle. This rate, around 15%, impacts treatment decisions like shunts or transplants.

Area of Science:

  • Pediatric Cardiology
  • Congenital Heart Disease Surgery
  • Neonatal Critical Care

Background:

  • Focus on interim mortality (post-discharge, pre-surgery death) in congenital heart defects.
  • Investigating interim mortality in infants with pulmonary atresia and intact ventricular septum receiving shunts.

Purpose of the Study:

  • To investigate interim mortality in infants undergoing systemic-to-pulmonary artery shunts for pulmonary atresia with intact ventricular septum.
  • To compare interim mortality rates with those of hypoplastic left heart syndrome.

Main Methods:

  • Retrospective analysis of 35 infants undergoing shunts for pulmonary atresia with intact septum over 11 years at two centers.
  • Infants classified into groups based on severe right ventricular hypoplasia (RVH) versus no severe RVH.
  • Data collected from institutional cardiology databases.

Main Results:

  • Mean infant age was 9 days, weight 3.1 kg.
  • 22 of 35 infants had severe right ventricular hypoplasia.
  • Overall interim mortality was 15% (5 of 33), exclusively in infants with severe right ventricular hypoplasia.

Conclusions:

  • A significant incidence of interim death occurs in infants with pulmonary atresia and hypoplastic right ventricle.
  • Interim mortality (15%) is comparable to hypoplastic left heart syndrome overall, and higher (24%) when severe RVH is present.
  • Interim mortality rates are critical considerations for treatment choices, including shunts versus transplant.
Abstract